Renowned entrepreneur Robert Langer discusses his journey of co-founding numerous companies and overcoming obstacles in bioengineering. He highlights pioneering work in drug delivery, tissue engineering, and the development of innovative medical technologies. From starting 40 companies to advancing research in neurological diseases, the podcast explores the transformative impact of Langer's groundbreaking innovations.
Robert Langer leveraged platform technologies and patents to commercialize bioengineering research into impactful clinical treatments.
Collaboration, persistence, and novel engineering approaches are key to getting discoveries from the lab into the world.
Deep dives
Robert Langer's Pursuit of Innovation
Robert Langer faced early career struggles but persisted in pursuing groundbreaking work in bioengineering, collaborating with Judah Folkman to revolutionize drug delivery in cancer treatment. Overcoming skepticism and resistance, Langer's engineering approach led to the development of nanoparticles for drug delivery, demonstrating success in inhibiting blood vessels and advancing medical treatment.
Building a Path to Commercialization
Despite facing initial resistance and rejection of patents, Langer's persistence and novel approaches led to the successful commercialization of his research. Starting his own company with a colleague, Langer leveraged platform technologies, animal data, publications, and patents to transition basic research into impactful clinical treatments, including artificial skin for burn victims and new drugs for various conditions.
Transformative Research in Tissue Engineering
Continuing his groundbreaking work in tissue engineering, Langer is exploring innovative applications such as creating a 'brain on a chip' and developing regenerative therapies for conditions like Alzheimer's and Parkinson's. His focus on platform technologies and interdisciplinary collaboration showcases the potential to revolutionize drug testing, reduce animal testing, and accelerate drug discovery for complex diseases.
Robert Langer has co-founded dozens of companies, holds over a thousand patents, and is a pioneering figure in drug delivery and tissue engineering. Robert has solved a lot of problems, and is working on many more with his lab at MIT. But there is one big problem that has stuck with Robert his whole career: How do you get discoveries out of the lab and into the world?